IEYCX
Price
$8.65
Change
+$0.08 (+0.93%)
Updated
Jul 3 closing price
Net Assets
99.23M
RSLDX
Price
$74.01
Change
+$0.43 (+0.58%)
Updated
Jul 3 closing price
Net Assets
78.69B
Interact to see
Advertisement

IEYCX vs RSLDX

Header iconIEYCX vs RSLDX Comparison
Open Charts IEYCX vs RSLDXBanner chart's image
Macquarie Climate Solutions C
Price$8.65
Change+$0.08 (+0.93%)
VolumeN/A
Net Assets99.23M
American Funds SMALLCAP World R5E
Price$74.01
Change+$0.43 (+0.58%)
VolumeN/A
Net Assets78.69B
IEYCX vs RSLDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IEYCX vs. RSLDX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IEYCX is a Buy and RSLDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 78.7B vs. IEYCX (99.2M). RSLDX pays higher dividends than IEYCX: RSLDX (0.81) vs IEYCX (0.47). IEYCX was incepted earlier than RSLDX: IEYCX (19 years) vs RSLDX (10 years). IEYCX (2.18) is less costly to investors than RSLDX (0.80). RSLDX is a more actively managed with annual turnover of: 32.00 vs. IEYCX (20.00). RSLDX has a lower initial minimum investment than IEYCX: RSLDX (250) vs IEYCX (1000). RSLDX annual gain was more profitable for investors over the last year : 10.63 vs. IEYCX (0.35). IEYCX return over 5 years is better than : 127.72 vs. RSLDX (22.93).
IEYCXRSLDXIEYCX / RSLDX
Total Expense Ratio1.990.80249%
Annual Report Gross Expense Ratio2.180.80273%
Fund Existence19 years10 years-
Gain YTD5.5428.73063%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets99.2M78.7B0%
Annual Yield % from dividends0.470.8158%
Returns for 1 year0.3510.633%
Returns for 3 years3.5335.7610%
Returns for 5 years127.7222.93557%
Returns for 10 years-29.10N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLCX11.87N/A
N/A
PGIM Jennison Health Sciences C
VVOCX19.67N/A
N/A
Invesco Value Opportunities C
NELIX63.12N/A
N/A
Nuveen Equity Long/Short I
DGEFX13.70N/A
N/A
Destinations Equity Income I
UIVVX12.70N/A
N/A
MFS Intrinsic Value A